Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Surmodics Inc (SRDX)

49.15 0.95 (1.97%)

05-22 16:00

Open:

48.15

Pre. Close:

48.2

High:

49.4

Low:

47.3

Volume:

168,084

Market Cap:

652M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

49.446 - 49.686

49.686 - 49.893

Low:

46.739 - 47.009

47.009 - 47.243

Close:

48.734 - 49.165

49.165 - 49.537

Technical analysis  (as of: 2018-05-22 4:43:08 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 57.76     One year: 67.46

Support:

Support1: 39.94    Support2: 34.06

Resistance:

Resistance1: 49.45    Resistance2: 57.76

Pivot:

45.17

Moving Averages:

MA(5): 48.63     MA(20): 43.24

MA(100): 34.55     MA(250): 30.77

MACD:

MACD(12,26): 2.96     Signal(12,26,9): 2.49

%K %D:

%K(14,3): 94.30     %D(3): 94.18

RSI:

RSI(14): 78.37

52-Week:

High: 49.45  Low: 22.65  Change(%): 115.8

Average Vol(K):

3-Month: 5928  10-Days 8065

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SRDX has closed below upper band by 19.8%. Bollinger Bands are 150.5% wider than normal. The large width of the bands suggest high volatility as compared to SRDX's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

2018-05-16T16:05:00-04:00
Surmodics Announces Leadership Change and Appointment of Interim CFO

2018-05-14T08:30:00-04:00
Surmodics Acquires Thrombectomy Technology Assets from Embolitech, Strengthening Peripheral Vascular Whole-Product Solutions Portfolio

2018-05-02T14:42:13-04:00
Surmodics' (SRDX) CEO Gary Maharaj on Q2 2018 Results - Earnings Call Transcript

2018-05-02T07:49:50-04:00
Surmodics beats by $0.15, beats on revenue

2018-05-02T07:30:00-04:00
CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance

2018-04-24T08:30:00-04:00
Surmodics to Webcast Second Quarter Fiscal 2018 Earnings Conference Call on May 2

2018-04-23T08:30:00-04:00
Surmodics Announces FDA Clearance of a New .018" Low-Profile PTA Balloon Dilation Catheter

2018-03-15T08:30:00-04:00
Surmodics to Present at Upcoming Investor Conferences

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Equipment Supplies Distribution

Shares Out. (M)

13.26

Shares Float (M)

9.66

% Held by Insiders

27.30

% Held by Institutions

85.60

Shares Short (K)

205

Shares Short Prior Month (K)

404

Stock Financials

EPS

0.420

EPS Est. Current Year

0.310

EPS Est. Next Year

0.230

EPS Est. Next Quarter

0.020

Forward EPS

0.110

Book Value (p.s.)

5.240

PEG Ratio

Profit Margin

1.53

Operating Margin

5.74

Return on Assets (ttm)

0.8

Return on Equity (ttm)

Qtrly Rev. Growth

-4.2

Gross Profit (p.s.)

3.450

Sales Per Share

EBITDA (p.s.)

0.452

Qtrly Earnings Growth

Operating Cash Flow (M)

12.72

Levered Free Cash Flow (M)

17.26

atoplab.com

Valuation

P/E

117.02

P/E Growth Ratio

0.02

P/BV

9.38

P/S

118066848.00

P/CF

51.23

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.